IL17A and cancer: Finally, culturing human CD4+ T-cells with anti-CD3 antibodies plus monocytes with the TLR ligand, LPS, has been shown to lead to the induction of IFNγ-secreting cells, IL-17-secreting cells and a third population of dual-secreting cells [42], which could be the most desirable outcome for cancer applications.